research Persistent hair growth during treatment with the EGFR inhibitor erlotinib
This review observes that trichomegaly, a newly described side effect of EGFR inhibitors causing excessive eyelash and scalp hair growth, persists in some patients whose tumors respond positively to the therapy.

